v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 20,336 $ 12,874 $ 39,797 $ 26,975
General and administrative 5,743 3,183 9,894 5,642
Total operating expenses 26,079 16,057 49,691 32,617
Loss from operations (26,079) (16,057) (49,691) (32,617)
Other income (expense), net:        
Interest income 2,858 335 4,077 808
Other (expense) income, net (832) 3,517 (1,114) 4,108
Total other income, net 2,026 3,852 2,963 4,916
Loss before income tax expense (24,053) (12,205) (46,728) (27,701)
Income tax (expense) benefit (97) (4) (109) 186
Net loss $ (24,150) $ (12,209) $ (46,837) $ (27,515)
Net loss per share, basic $ (0.8) $ (12.91) $ (3) $ (29.09)
Net loss per share, diluted $ (0.8) $ (12.91) $ (3) $ (29.09)
Weighted average shares outstanding, basic 30,111,338 946,000 15,609,236 946,000
Weighted average shares outstanding, diluted 30,111,338 946,000 15,609,236 946,000
Other comprehensive loss        
Net Income (Loss) $ (24,150) $ (12,209) $ (46,837) $ (27,515)
Net unrealized (loss) gain on available-for-sale debt securities (2,309) (609) (2,923) 365
Total comprehensive loss $ (26,459) $ (12,818) $ (49,760) $ (27,150)